Functionalization of Liposomes with Hydrophilic Polymers Results in Macrophage Uptake Independent of the Protein Corona

被引:76
作者
Weber, Claudia [1 ]
Voigt, Matthias [2 ]
Simon, Johanna [1 ,3 ]
Danner, Ann-Kathrin [4 ]
Frey, Holger [4 ]
Mailaender, Volker [1 ,3 ]
Helm, Mark [2 ]
Morsbach, Svenja [1 ]
Landfester, Katharina [1 ]
机构
[1] Max Planck Inst Polymer Res, Ackermannweg 10, D-55128 Mainz, Germany
[2] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, Staudingerweg 5, D-55128 Mainz, Germany
[3] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Dermatol, Langenbeckstr 1, D-55131 Mainz, Germany
[4] Johannes Gutenberg Univ Mainz, Inst Organ Chem, Duesbergweg 10-14, D-55128 Mainz, Germany
关键词
PEG CHAIN-LENGTH; DRUG-DELIVERY; PROLONGED CIRCULATION; NANOPARTICLES; DOXORUBICIN; NANOMEDICINES; ADSORPTION; LIPIDS; HARD; TIME;
D O I
10.1021/acs.biomac.9b00539
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Liposomes are established drug carriers that are employed to transport and deliver hydrophilic drugs in the body. To minimize unspecific cellular uptake, nanocarriers are commonly modified with poly(ethylene glycol) (PEG), which is known to minimize unspecific protein adsorption. However, to date, it has not been studied whether this is an intrinsic and specific property of PEG or if it can be transferred to hyperbranched polyglycerol (hbPG) as well. Additionally, it remains unclear if the reduction of unspecific cell uptake is independent of the "basic" carrier at which a surface functionalization with polymers is usually applied. Therefore, we studied the protein corona of differently functionalized liposomes (unfunctionalized vs PEG or hbPG-functionalized) using PEGylated and PGylated lipids. Their cellular uptake in macrophages was compared. For all three liposomal samples, rather similar protein corona compositions were found, and also-more importantly-the total amount of proteins adsorbed was very low compared to other nanoparticles. Interestingly, the cellular uptake was then significantly changed by the surface functionalization itself, despite the adsorption of a small amount of proteins: although the PEGylation of liposomes resulted in the abovementioned decreased cell uptake, functionalization with hbPG lead to enhanced macrophage interaction-both in the media with and without proteins. In comparison to other nanocarrier systems, this seems to be a liposome-specific effect related to the low amount of adsorbed proteins.
引用
收藏
页码:2989 / 2999
页数:11
相关论文
共 56 条
[1]   Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy [J].
Aggarwal, Parag ;
Hall, Jennifer B. ;
McLeland, Christopher B. ;
Dobrovolskaia, Marina A. ;
McNeil, Scott E. .
ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (06) :428-437
[2]   Liposome: classification, preparation, and applications [J].
Akbarzadeh, Abolfazl ;
Rezaei-Sadabady, Rogaie ;
Davaran, Soodabeh ;
Joo, Sang Woo ;
Zarghami, Nosratollah ;
Hanifehpour, Younes ;
Samiei, Mohammad ;
Kouhi, Mohammad ;
Nejati-Koshki, Kazem .
NANOSCALE RESEARCH LETTERS, 2013, 8
[3]   PEG-Peptide Inhibition of Scavenger Receptor Uptake of Nanoparticles by the Liver [J].
Allen, Rondine J. ;
Mathew, Basil ;
Rice, Kevin G. .
MOLECULAR PHARMACEUTICS, 2018, 15 (09) :3881-3891
[4]   Drug delivery systems: Entering the mainstream [J].
Allen, TM ;
Cullis, PR .
SCIENCE, 2004, 303 (5665) :1818-1822
[5]   Structure Activity Relationship of PEGylated Polylysine Peptides as Scavenger Receptor Inhibitors for Non-Viral Gene Delivery [J].
Baumhover, Nicholas J. ;
Duskey, Jason T. ;
Khargharia, Sanjib ;
White, Christopher W. ;
Crowley, Samuel T. ;
Allen, Rondine J. ;
Rice, Kevin G. .
MOLECULAR PHARMACEUTICS, 2015, 12 (12) :4321-4328
[6]   Exploring Cellular Interactions of Liposomes Using Protein Corona Fingerprints and Physicochemical Properties [J].
Bigdeli, Arafeh ;
Palchetti, Sara ;
Pozzi, Daniela ;
Hormozi-Nezhad, Mohammad Reza ;
Bombelli, Francesca Baldelh ;
Caracciolo, Giulio ;
Mahmoudi, Morteza .
ACS NANO, 2016, 10 (03) :3723-3737
[7]   Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date [J].
Bobo, Daniel ;
Robinson, Kye J. ;
Islam, Jiaul ;
Thurecht, Kristofer J. ;
Corrie, Simon R. .
PHARMACEUTICAL RESEARCH, 2016, 33 (10) :2373-2387
[8]   The liposome-protein corona in mice and humans and its implications for in vivo delivery [J].
Caracciolo, G. ;
Pozzi, D. ;
Capriotti, A. L. ;
Cavaliere, C. ;
Piovesana, S. ;
La Barbera, G. ;
Amici, A. ;
Lagana, A. .
JOURNAL OF MATERIALS CHEMISTRY B, 2014, 2 (42) :7419-7428
[9]   Liposome-protein corona in a physiological environment: Challenges and opportunities for targeted delivery of nanomedicines [J].
Caracciolo, Giulio .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2015, 11 (03) :543-557
[10]   Personalized liposome-protein corona in the blood of breast, gastric and pancreatic cancer patients [J].
Colapicchioni, Valentina ;
Tilio, Martina ;
Digiacomo, Luca ;
Gambini, Valentina ;
Palchetti, Sara ;
Marchini, Cristina ;
Pozzi, Daniela ;
Occhipinti, Sergio ;
Amici, Augusto ;
Caracciolo, Giulio .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2016, 75 :180-187